BIOTAGE AB SK 1 revenue breakdown overview

BIOTAGE AB SK 1 revenue for the last year amounted to 166.46 M EUR, the most of which — 58.48 M EUR — came from its highest performing source at the moment, Small Molecules & Synthetic Therapeutics, the year earlier bringing 68.71 M EUR. The greatest contribution to the revenue figure was made by North and South America — last year it brought BIOTAGE AB SK 1 66.89 M EUR, and the year before that — 58.89 M EUR.